#100000
Who would I report to? <a href=" http://surfsideonthelake.com/motor-coach-group-tours/ ">how much does levofloxacin cost without insurance</a> Drugmaker Retrophin Inc said it offered to buy therest of Transcept Pharmaceuticals shares it does not already ownfor $4 per share, valuing Transcept at about $75 million.Retrophin's offer represents an 11 percent premium toTranscept's closing share price of $3.59 on the Nasdaq onWednesday.
Submitted by Anonymous (not verified) on Tue, 10/28/2014 - 18:08 to Technology |
